* Says gets 30-day extension from its bond holders
* Says talks related to restructuring of debt to continue
* Shares up 6 pct before the bell
April 16 (Reuters) - Molecular Insight Pharmaceuticals Inc MIPI.O said it received a 30-day extension of its waiver agreement with its bond holders, sending its shares up as much as 6 percent in pre-market trade.
The extension will allow its talks with bondholders, related to restructuring of its outstanding debt, to continue, the biopharmaceutical company said in a statement.
The term of the waiver is extended until May 18, it said.
In March, the company said its auditors had expressed doubts on its ability to continue as a going concern, partly due to recurring losses from its operations. [ID:nSGE62F0HC]
Shares of the company closed at $2.73 Thursday on Nasdaq. (Reporting by Shailesh Kuber in Bangalore; Editing by Gopakumar Warrier)